The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of Codex DNA, Inc. is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: February 1, 2022
| | DANAHER CORPORATION |
| | |
| | |
| | By: | /s/ Jose-Carlos Gutierrez-Ramos |
| | Name: | Jose-Carlos Gutierrez-Ramos |
| | Title: | Senior Vice President and Chief Science Officer |
| | |
| | |
| | DANAHER INNOVATION CENTER LLC |
| | |
| | |
| | By: | /s/ Jose-Carlos Gutierrez-Ramos |
| | Name: | Jose-Carlos Gutierrez-Ramos |
| | Title: | President |
